QT
EGRX

Quantbot Technologies’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Quantbot Technologies’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,200
Closed -$6.29K – 2005
2024
Q1 		$6.29K Sell
1,200
-2,000
-63% -$11K ﹤0.01% 1477
2023
Q4 		$16.7K Buy
3,200
+800
+33% +$7.9K ﹤0.01% 1439
2023
Q3 		$37.8K Sell
2,400
-2,700
-53% -$48.5K ﹤0.01% 1288
2023
Q2 		$99.1K Buy
5,100
+43
+0.9% +$1.02K 0.01% 1181
2023
Q1 		$143K Buy
+5,057
New +$150K 0.01% 993
2022
Q4 		– Sell
-1,700
Closed -$44K – 2206
2022
Q3 		$44K Buy
+1,700
New +$62.4K ﹤0.01% 1266
2020
Q4 		– Sell
-225
Closed -$9K – 1764
2020
Q3 		$9K Buy
+225
New +$9.84K ﹤0.01% 1133
2018
Q3 		– Sell
-129
Closed -$9K – 1614
2018
Q2 		$9K Buy
+129
New +$8.12K ﹤0.01% 1112
2017
Q3 		– Sell
-10
Closed – – 1479
2017
Q2 		$0 Buy
+10
New +$818 ﹤0.01% 1443
2016
Q1 		– Sell
-913
Closed -$80K – 1457
2015
Q4 		$80K Buy
+913
New +$72.1K 0.01% 709
2015
Q3 		– Sell
-960
Closed -$77K – 1466
2015
Q2 		$77K Sell
960
-1,475
-61% -$96.1K 0.01% 720
2015
Q1 		$102K Buy
+2,435
New +$69.1K 0.03% 606

Other funds holding EGRX

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Quantbot Technologies's EGRX Position: Q2 2024 in Review

Quantbot Technologies sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q2 2024, closing a stake of 1,200 shares — an estimated $6.29K sold.

Quantbot Technologies first reported a position in EGRX in Q1 2015 and held it in 12 quarters. The position peaked at $143K in Q1 2023. 75 funds tracked by Wall St. Rank hold EGRX as of Q2 2024.

  • Quantbot Technologies reported no remaining Eagle Pharmaceuticals, Inc. position as of Q2 2024 after selling out during the quarter.
  • Quantbot Technologies sold 1,200 Eagle Pharmaceuticals, Inc. shares in Q2 2024, an estimated $6.29K.
  • Quantbot Technologies first reported a position in Eagle Pharmaceuticals, Inc. in Q1 2015 and held it in 12 quarters.
  • Quantbot Technologies's Eagle Pharmaceuticals, Inc. position peaked at $143K in Q1 2023.
  • 75 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q2 2024.

Based on Quantbot Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.